Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001855393 | SCV002127697 | uncertain significance | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with hydrocephalus (PMID: 28556411). ClinVar contains an entry for this variant (Variation ID: 548150). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with threonine at codon 1760 of the MPDZ protein (p.Ala1760Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. |
OMIM | RCV000660888 | SCV000783121 | pathogenic | Hydrocephalus, nonsyndromic, autosomal recessive 2 | 2018-07-10 | no assertion criteria provided | literature only | |
Biochemical Molecular Genetic Laboratory, |
RCV000660888 | SCV001132846 | uncertain significance | Hydrocephalus, nonsyndromic, autosomal recessive 2 | 2019-01-29 | no assertion criteria provided | clinical testing |